{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:00:16Z","timestamp":1761487216720},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1987,4,1]],"date-time":"1987-04-01T00:00:00Z","timestamp":544233600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[1987,4]]},"DOI":"10.1007\/bf00216016","type":"journal-article","created":{"date-parts":[[2004,9,17]],"date-time":"2004-09-17T05:17:51Z","timestamp":1095398271000},"page":"489-495","source":"Crossref","is-referenced-by-count":104,"title":["Cognitive effects of l-deprenyl in Alzheimer's disease"],"prefix":"10.1007","volume":"91","author":[{"given":"P.N.","family":"Tariot","sequence":"first","affiliation":[]},{"given":"T.","family":"Sunderland","sequence":"additional","affiliation":[]},{"given":"H.","family":"Weingartner","sequence":"additional","affiliation":[]},{"given":"D.L.","family":"Murphy","sequence":"additional","affiliation":[]},{"given":"J.A.","family":"Welkowitz","sequence":"additional","affiliation":[]},{"given":"K.","family":"Thompson","sequence":"additional","affiliation":[]},{"given":"R.M.","family":"Cohen","sequence":"additional","affiliation":[]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1192\/bjp.135.3.216","volume":"135","author":"R Adolfsson","year":"1979","unstructured":"Adolfsson R, Gottfries CG, Roos BE, Winblad B (1979) Changes in brain catecholamines in patients with dementia of Alzheimer type. Br J Psychiatry 135:216?223","journal-title":"Br J Psychiatry"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/0024-3205(80)90025-9","volume":"17","author":"R Adolfsson","year":"1980","unstructured":"Adolfsson R, Gottfries CG, Oreland L, Wiberg A, Winblad B (1980) Increased activity of brain and platelet monoamine oxidase in dementia of Alzheimer type. Life Sci 17:1029?1034","journal-title":"Life Sci"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1126\/science.181.4100.682","volume":"181","author":"GM Anzelark","year":"1973","unstructured":"Anzelark GM, Crow TJ, Greenway AP (1973) Impaired learning and decreased cortical norepinephrine after bilateral locus coeruleus lesions. Science 181:682?684","journal-title":"Science"},{"issue":"2","key":"CR4","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1471-4159.1984.tb00913.x","volume":"43","author":"H Arai","year":"1984","unstructured":"Arai H, Kosaka K, Iizuka R (1984) Changes of biogenic amines and their metabolites in postmortem brains from patients with Alzheimer-type dementia. J Neurochem 43(2):388?393","journal-title":"J Neurochem"},{"issue":"2","key":"CR5","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/00002826-198205020-00004","volume":"5","author":"W Birkmayer","year":"1982","unstructured":"Birkmayer W, Riederer P, Youdim MBH (1982) (-) Deprenyl in the treatment of Parkinson's disease. Clin Neuropharmacol 5(2):195?230","journal-title":"Clin Neuropharmacol"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1212\/WNL.32.2.164","volume":"32","author":"W Bondareff","year":"1982","unstructured":"Bondareff W, Mountjoy CQ, Roth M (1982) Loss of neurons of origin of the adrenergic projection to cerebral cortex (nucleus locus coeruleus) in senile dementia. Neurology 32:164?168","journal-title":"Neurology"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0197-4580(83)90038-6","volume":"4","author":"S Brinkman","year":"1983","unstructured":"Brinkman S, Gershon S (1983) Measurement of cholinergic drug effect on memory in Alzheimer's disease. Neurobiol Aging 4:139?145","journal-title":"Neurobiol Aging"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0022-5371(73)80034-9","volume":"12","author":"H Buschke","year":"1973","unstructured":"Buschke H (1973) Selective reminding for the analysis of memory and learning. J Verb Learn Verb Behav 12:543?550","journal-title":"J Verb Learn Verb Behav"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1532-5415.1979.tb06442.x","volume":"27","author":"ANG Clark","year":"1979","unstructured":"Clark ANG, Mankikar GD (1979) d-Amphetamine in elderly patients refractory to rehabilitation procedures. J Am Geriatr Soc 27:174?177","journal-title":"J Am Geriatr Soc"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1001\/archpsyc.1982.04290050061012","volume":"32","author":"RM Cohen","year":"1982","unstructured":"Cohen RM, Weingartner H, Smallberg SA, Pickar D, Murphy DL (1982) Effort and cognition in depression. Arch Gen Psychiatry 32:593?597","journal-title":"Arch Gen Psychiatry"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0165-1781(83)90100-2","volume":"8","author":"RM Cohen","year":"1983","unstructured":"Cohen RM, Cohen MR, Weingartner H, Pickar D, Murphy DL (1983) Naloxone affects task performance in normal subjects. Psychiatry Res 8:127?136","journal-title":"Psychiatry Res"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/ddr.430040507","volume":"4","author":"RM Cohen","year":"1984","unstructured":"Cohen RM, Sunderland T, Aulakh CS (1984) Antidepressants in states of cognitive dysfunction. Drug Dev Res 4:517?532","journal-title":"Drug Dev Res"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/BF00426708","volume":"52","author":"T Crook","year":"1977","unstructured":"Crook T, Ferris S, Sathananthan G, Raskin A, Gershon S (1977) The effect of methylphenidate on test performance in the cognitively impaired aged. Psychopharmacology 52:251?257","journal-title":"Psychopharmacology"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1136\/bmj.282.6258.93","volume":"282","author":"AJ Cross","year":"1981","unstructured":"Cross AJ, Crow TJ, Perry EK, Perry RH, Blessed G, Tomlinson BE (1981) Reduced dopamine-beta-hydroxylase activity in Alzheimer's disease. Br Med J 282:93?94","journal-title":"Br Med J"},{"key":"CR15","first-page":"651","volume-title":"Signal detection and recognition by human observers","author":"PB Elliott","year":"1964","unstructured":"Elliott PB (1964) Tables of d1. In: Swets JA (ed) Signal detection and recognition by human observers. Wiley, New York, pp 651?684"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/BF00426954","volume":"57","author":"JD Ellsworth","year":"1978","unstructured":"Ellsworth JD, Glover V, Reynolds GP, Sandler M, Lees AJ, Phuapradit P, Shaw KM, Stein GM, Kumar P (1978) Deprenyl administration in man: A selective monoamine oxidase inhibitor without the ?cheese? effect. Psychopharmacology 57:33?38","journal-title":"Psychopharmacology"},{"issue":"1","key":"CR17","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1056\/NEJM198507043130102","volume":"313","author":"PT Francis","year":"1985","unstructured":"Francis PT, Palmer AM, Sims NR, Bowen DM, Davison AN, Esiri MM, Neary D, Snowdon JS, Wilcock GK (1985) Neurochemical studies of early-onset Alzheimer's disease: Possible influence on treatment. N Engl J Med 313(1):7?11","journal-title":"N Engl J Med"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/ana.410110208","volume":"11","author":"PA Fuld","year":"1982","unstructured":"Fuld PA, Katzman R, Davies P, Terry RD (1982) Intrusions as a sign of Alzheimer dementia: Chemical and pathological verification. Ann Neurol 11:155?159","journal-title":"Ann Neurol"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1001\/archpsyc.1981.01780340100012","volume":"38","author":"RM Glass","year":"1981","unstructured":"Glass RM, Uhlenhuth EH, Hartel FW, Matuzas W, Fischman MW (1981) Cognitive dysfunction and imipramine in outpatient depressives. Arch Gen Psychiatry 38:1048?1051","journal-title":"Arch Gen Psychiatry"},{"key":"CR20","first-page":"1","volume-title":"Catecholamines and behavior, vol 2","author":"DA Gorelick","year":"1975","unstructured":"Gorelick DA, Bozewicz TR, Bridger WH (1975) The role of catecholamines in animal learning and memory. In: Friedhoff AJ (ed) Catecholamines and behavior, vol 2. Plenum, New York, pp 1?30"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/BF00432208","volume":"86","author":"CG Gottfries","year":"1985","unstructured":"Gottfries CG (1985) Alzheimer's disease and senile dementia: biochemical characteristics and aspects of treatment. Psychopharmacology 86:245?252","journal-title":"Psychopharmacology"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.2044-8260.1967.tb00530.x","volume":"6","author":"M Hamilton","year":"1967","unstructured":"Hamilton M (1967) Development of a rating scale for primary depressive illness. Br J Soc Psychol 6:278?296","journal-title":"Br J Soc Psychol"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1037\/0096-3445.108.3.356","volume":"108","author":"L Hasher","year":"1979","unstructured":"Hasher L, Zacks RJ (1979) Automatic and effortful processes in memory. J Exp Psychol [Gen] 108:386?388","journal-title":"J Exp Psychol [Gen]"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1176\/ajp.130.9.966","volume":"130","author":"GM Henry","year":"1973","unstructured":"Henry GM, Weingartner H, Murphy DL (1973) The influence of affective states and psychoactive drugs on verbal learning and memory. Am J Psychiatry 130:966?971","journal-title":"Am J Psychiatry"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1126\/science.6091272","volume":"226","author":"NF Hopkins","year":"1984","unstructured":"Hopkins NF, Johnston D (1984) Frequency-dependent noradrenergic modulation of long-term potentiation in the hippocampus. Science 226:350?352","journal-title":"Science"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1212\/WNL.32.5.503","volume":"32","author":"F Karoum","year":"1982","unstructured":"Karoum F, Chuang L-W, Eisler T, Calne DB, Liebowitz MR, Quitkin MR, Klein DF, Wyatt RJ (1982) Metabolism of (-) deprenyl to amphetamine and methamphetamine. Neurology 32:503?509","journal-title":"Neurology"},{"key":"CR27","first-page":"324","volume-title":"The neurosciences: second study program","author":"SF Kety","year":"1970","unstructured":"Kety SF (1970) The biogenic amines in the central nervous system: Their possible roles in arousal, emotion, and learning. In: Schmitt FO (ed) The neurosciences: second study program. Rockefeller Press, New York, pp 324?336"},{"key":"CR28","doi-asserted-by":"crossref","unstructured":"Knoll J (1976) Analysis of the pharmacological effects of selective monoamine oxidase inhibitors. CIBA Foundation Symposium 39, Monoamine oxidase and its inhibition. Elsevier\/North Holland, Excerpta Medical, pp 135?161","DOI":"10.1002\/9780470720219.ch8"},{"issue":"1","key":"CR29","first-page":"154","volume":"155","author":"J Knoll","year":"1965","unstructured":"Knoll J, Ecseri Z, Kelmen K, Nievel J, Knoll B (1965) Phenylisopropylmethylpropinylamine (E-250), a new spectrum psychic energizer. Arch Int Pharmacodyn Ther 155(1):154?164","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1192\/bjp.136.6.533","volume":"136","author":"DA Mann","year":"1980","unstructured":"Mann DA, Lincoln J, Yates PO, Stamp JE, Toper S (1980) Changes in the monoamine containing neurons of the human CNS in senile dementia. Br J Psychiatry 136:533?541","journal-title":"Br J Psychiatry"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/00004714-198202000-00008","volume":"2","author":"JJ Mann","year":"1982","unstructured":"Mann JJ, Frances A, Kaplan R, Kocsis J, Peselow ED, Gershon S (1982) The relative efficacy of l-deprenyl, a selective monoamine oxidase type B inhibitor, in endogenous and nonendogenous depression. J Clin Psychopharmacol 2:54?57","journal-title":"J Clin Psychopharmacol"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1146\/annurev.ps.34.020183.001501","volume":"34","author":"JL McGaugh","year":"1983","unstructured":"McGaugh JL (1983) Hormonal influences on memory. Annu Rev Psychol 34:297?323","journal-title":"Annu Rev Psychol"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","volume":"34","author":"G McKhann","year":"1984","unstructured":"McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group. Neurology 34:939?944","journal-title":"Neurology"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/BF00431109","volume":"73","author":"N Mendis","year":"1981","unstructured":"Mendis N, Pare CMB, Sandler M, Glover V, Stern GM (1981) Is the failure of (-) deprenyl, a selective MAO B inhibitor, to alleviate depression related to freedom from cheese effect? Psychopharmacology 73:87?90","journal-title":"Psychopharmacology"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1192\/bjp.142.5.508","volume":"142","author":"J Mendlewicz","year":"1983","unstructured":"Mendlewicz J, Youdim MBH (1983) l-Deprenil, a selective monoamine oxidase type B inhibitor, in the treatment of depression: A double-blind evaluation. Br J Psychiatry 142:508?511","journal-title":"Br J Psychiatry"},{"key":"CR36","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1001\/archneur.1986.00520030031008","volume":"43","author":"MB Moss","year":"1986","unstructured":"Moss MB, Albert MS, Butters N, Payne M (1986) Differential patterns of memory loss among patients with Alzheimer's disease, Huntington's disease, and alcoholic Korsakoff's syndrome. Arch Neurol 43:239?246","journal-title":"Arch Neurol"},{"key":"CR37","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/BF00429385","volume":"27","author":"DL Murphy","year":"1972","unstructured":"Murphy DL, Henry GM, Weingartner H (1972) Catecholamines and memory: Enhanced verbal learning during l-dopa administration. Psychopharmacologia 27:319?326","journal-title":"Psychopharmacologia"},{"key":"CR38","volume-title":"Word association norms: Grade school through college","author":"DS Palermo","year":"1964","unstructured":"Palermo DS, Jenkins JJ (1964) Word association norms: Grade school through college. Univ Minnesota Press, Minneapolis"},{"key":"CR39","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1001\/archpsyc.1984.01790190051006","volume":"41","author":"FM Quitkin","year":"1984","unstructured":"Quitkin FM, Liebowitz MR, Stewart JW, McGrath PJ, Harrison W, Rabkin JG, Markowitz J, Davies SO (1984) l-Deprenyl in atypical depressives. Arch Gen Psychiatry 41:777?781","journal-title":"Arch Gen Psychiatry"},{"issue":"9","key":"CR40","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1176\/ajp.139.9.1136","volume":"139","author":"B Reisberg","year":"1982","unstructured":"Reisberg B, Ferris SH, DeLeon MJ, Crook T (1982) The global deterioration scale for assessment of primary degenerative dementia. Am J Psychiatry 139(9):1136?1139","journal-title":"Am J Psychiatry"},{"key":"CR41","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/j.1365-2125.1978.tb00883.x","volume":"6","author":"GP Reynolds","year":"1978","unstructured":"Reynolds GP, Elsworth JD, Blau K, Sandler M, Lees AJ, Stern GM (1978) Deprenyl is metabolized to amphetamine and methamphetamine in man. Br J Clin Pharmacol 6:542?543","journal-title":"Br J Clin Pharmacol"},{"key":"CR42","first-page":"345","volume":"14","author":"VI Reus","year":"1979","unstructured":"Reus VI, Silberman E, Post RM, et al. (1979) d-Amphetamine: Effects on memory in a depressed population. Biol Psychiatry 14:345?356","journal-title":"Biol Psychiatry"},{"key":"CR43","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S0140-6736(72)90293-0","volume":"I","author":"DS Robinson","year":"1972","unstructured":"Robinson DS, Davis JM, Nies A, Colburn RW, Davis JN, Bourne HR, Bunney WE, Shaw DM, Coppen AJ (1972) Ageing, monoamines, and monoamine oxidase levels. Lancet I:290?291","journal-title":"Lancet"},{"key":"CR44","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1136\/bmj.288.6422.961","volume":"288","author":"MN Rossor","year":"1984","unstructured":"Rossor MN, Iversen LL, Reynolds GP, Mountjoy CO, Roth M (1984) Neurochemical characteristics of early and late onset types of Alzheimer's disease. Br Med J 288:961?964","journal-title":"Br Med J"},{"key":"CR45","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1037\/h0043220","volume":"20","author":"HE Rosvold","year":"1956","unstructured":"Rosvold HE, Mirsky AF, Sarason I (1956) A continuous performance test of brain damage. J Consult Clin Psychol 20:343?350","journal-title":"J Consult Clin Psychol"},{"key":"CR46","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1001\/archpsyc.1986.01800030083008","volume":"43","author":"PP Roy-Byrne","year":"1986","unstructured":"Roy-Byrne PP, Weingartner H, Bierer L, Thompson K, Post RM (1986) Effortful and automatic cognitive processes in depression. Arch Gen Psychiatry 43:265?267","journal-title":"Arch Gen Psychiatry"},{"key":"CR47","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1146\/annurev.pa.21.040181.001543","volume":"21","author":"LR Squire","year":"1981","unstructured":"Squire LR, Davis HP (1981) The pharmacology of memory: A neurobiological perspective. Annu Rev Pharmacol Toxicol 21:323?356","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"CR48","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1001\/archpsyc.1976.01770020055009","volume":"33","author":"DE Sternberg","year":"1976","unstructured":"Sternberg DE, Jarvik ME (1976) Memory functions in depression: Improvement with antidepressant medication. Arch Gen Psychiatry 33:219?224","journal-title":"Arch Gen Psychiatry"},{"key":"CR49","doi-asserted-by":"crossref","unstructured":"Sunderland T, Tariot PN, Cohen RM, Weingartner H, Mueller EA, Murphy DL (1987) Anticholinergic sensitivity in Alzheimer patients and age-matched controls. Arch Gen Psychiatry (in press)","DOI":"10.1001\/archpsyc.1987.01800170032006"},{"key":"CR50","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1001\/archpsyc.1986.01800080013002","volume":"43","author":"PN Tariot","year":"1986","unstructured":"Tariot PN, Sunderland T, Weingartner H, Murphy DL, Cohen MR, Cohen RM (1986) Naloxone and Alzheimer's disease. Arch Gen Psychiatry 43:727?732","journal-title":"Arch Gen Psychiatry"},{"key":"CR51","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1001\/archpsyc.1986.01800120069014","volume":"43","author":"PN Tariot","year":"1986","unstructured":"Tariot PN, Weingartner H (1986) A psychobiologic analysis of cognitive failures: Structure and mechanisms. Arch Gen Psychiatry 43:1183?1188","journal-title":"Arch Gen Psychiatry"},{"key":"CR52","doi-asserted-by":"crossref","unstructured":"Tariot PN, Cohen RM, Sunderland T, Newhouse PA, Yount D, Mellow AM, Weingartner H, Mueller EA, Murphy DL (1987) l-deprenyl in Alzheimer's disease: preliminary evidence for behavioral change with MAO-B inhibition. Arch Gen Psychiatry (in press)","DOI":"10.1001\/archpsyc.1987.01800170041007"},{"key":"CR53","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1001\/archpsyc.1981.01780260044004","volume":"38","author":"H Weingartner","year":"1981","unstructured":"Weingartner H, Cohen RM, Murphy DL, Martello J, Gerdt C (1981) Cognitive processes in depression. Arch Gen Psychiatry 38:42?47","journal-title":"Arch Gen Psychiatry"},{"key":"CR54","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1126\/science.6867715","volume":"221","author":"H Weingartner","year":"1983","unstructured":"Weingartner H, Grafman J, Boutelle W, Kaye W, Martin PR (1983) Forms of memory failure. Science 221:380?382","journal-title":"Science"},{"key":"CR55","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0006-8993(78)90253-6","volume":"152","author":"RA Wise","year":"1978","unstructured":"Wise RA (1978) Catecholamine theories of reward: A critical review. Brain Res 152:215?247","journal-title":"Brain Res"},{"key":"CR56","first-page":"12","volume":"47","author":"SW Woods","year":"1986","unstructured":"Woods SW, Tesar GE, Murray GB, Cassem NH (1986) Psychostimulant treatment of depressive disorders secondary to medical illness. J Clin Psychiatry 47:12?15","journal-title":"J Clin Psychiatry"},{"key":"CR57","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0006-8993(83)91179-4","volume":"280","author":"CM Yates","year":"1983","unstructured":"Yates CM, Simpson J, Gordon A, Maloney AFJ, Allison Y, Ritchie IM, Urquhart A (1983) Catecholamines and cholinergic enzymes in pre-senile and senile Alzheimer-type dementia and Down's syndrome. Brain Res 280:119?126","journal-title":"Brain Res"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00216016.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00216016\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00216016","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,9]],"date-time":"2019-04-09T04:12:03Z","timestamp":1554783123000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00216016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1987,4]]},"references-count":57,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1987,4]]}},"alternative-id":["BF00216016"],"URL":"https:\/\/doi.org\/10.1007\/bf00216016","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[1987,4]]}}}